Yes, Samsung. But what makes them so outstanding?
It's approved Mfgr'ng for a plethora of companies.

We would be the opposite need --- 1 drug covering a plethora of indications.

We don't / wouldn't, have anywhere near the typical facility build costs.

Actually, I think it would be the "easiest" & record low cost facility build.

1 drug facility, jointly owned by a Cytodyn partnership, pumping out Ohm's list of 90.

We know the drug is potentially unprecedented.

So why stop there ?

Just more frwd blabber thinking .....